Cargando…

Dual-Energy CT Pulmonary Angiography (DECTPA) Quantifies Vasculopathy in Severe COVID-19 Pneumonia

BACKGROUND: The role of dual energy computed tomographic pulmonary angiography (DECTPA) in revealing vasculopathy in coronavirus disease 2019 (COVID-19) has not been fully explored. PURPOSE: To evaluate the relationship between DECTPA and disease duration, right ventricular dysfunction (RVD), lung c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridge, Carole A, Desai, Sujal R, Jeyin, Nidhish, Mahon, Ciara, Lother, Dione L, Mirsadraee, Saeed, Semple, Tom, Price, Susanna, Bleakley, Caroline, Arachchillage, Deepa J, Shaw, Elizabeth, Patel, Brijesh V, Padley, Simon PG, Devaraj, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radiological Society of North America 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605077/
https://www.ncbi.nlm.nih.gov/pubmed/33778632
http://dx.doi.org/10.1148/ryct.2020200428
_version_ 1783604246584754176
author Ridge, Carole A
Desai, Sujal R
Jeyin, Nidhish
Mahon, Ciara
Lother, Dione L
Mirsadraee, Saeed
Semple, Tom
Price, Susanna
Bleakley, Caroline
Arachchillage, Deepa J
Shaw, Elizabeth
Patel, Brijesh V
Padley, Simon PG
Devaraj, Anand
author_facet Ridge, Carole A
Desai, Sujal R
Jeyin, Nidhish
Mahon, Ciara
Lother, Dione L
Mirsadraee, Saeed
Semple, Tom
Price, Susanna
Bleakley, Caroline
Arachchillage, Deepa J
Shaw, Elizabeth
Patel, Brijesh V
Padley, Simon PG
Devaraj, Anand
author_sort Ridge, Carole A
collection PubMed
description BACKGROUND: The role of dual energy computed tomographic pulmonary angiography (DECTPA) in revealing vasculopathy in coronavirus disease 2019 (COVID-19) has not been fully explored. PURPOSE: To evaluate the relationship between DECTPA and disease duration, right ventricular dysfunction (RVD), lung compliance, D-dimer and obstruction index in COVID-19 pneumonia. MATERIALS AND METHODS: This institutional review board approved this retrospective study, and waived the informed consent requirement. Between March-May 2020, 27 consecutive ventilated patients with severe COVID-19 pneumonia underwent DECTPA to diagnose pulmonary thrombus (PT); 11 underwent surveillance DECTPA 14 ±11.6 days later. Qualitative and quantitative analysis of perfused blood volume (PBV) maps recorded: i) perfusion defect ‘pattern’ (wedge-shaped, mottled or amorphous), ii) presence of PT and CT obstruction index (CTOI) and iii) PBV relative to pulmonary artery enhancement (PBV/PAenh); PBV/PAenh was also compared with seven healthy volunteers and correlated with D-Dimer and CTOI. RESULTS: Amorphous (n=21), mottled (n=4), and wedge-shaped (n=2) perfusion defects were observed (M=20; mean age=56 ±8.7 years). Mean extent of perfusion defects=36.1%±17.2. Acute PT was present in 11/27(40.7%) patients. Only wedge-shaped defects corresponded with PT (2/27, 7.4%). Mean CTOI was 2.6±5.4 out of 40. PBV/PAenh (18.2 ±4.2%) was lower than in healthy volunteers (27 ±13.9%, p = 0.002). PBV/PAenh correlated with disease duration (β = 0.13, p = 0.04), and inversely correlated with RVD (β = -7.2, p = 0.001), persisting after controlling for confounders. There were no linkages between PBV/PAenh and D-dimer or CTOI. CONCLUSION: Perfusion defects and decreased PBV/PAenh are prevalent in severe COVID-19 pneumonia. PBV/PAenh correlates with disease duration and inversely correlates with RVD. PBV/PAenh may be an important marker of vasculopathy in severe COVID-19 pneumonia even in the absence of arterial thrombus.
format Online
Article
Text
id pubmed-7605077
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Radiological Society of North America
record_format MEDLINE/PubMed
spelling pubmed-76050772020-11-06 Dual-Energy CT Pulmonary Angiography (DECTPA) Quantifies Vasculopathy in Severe COVID-19 Pneumonia Ridge, Carole A Desai, Sujal R Jeyin, Nidhish Mahon, Ciara Lother, Dione L Mirsadraee, Saeed Semple, Tom Price, Susanna Bleakley, Caroline Arachchillage, Deepa J Shaw, Elizabeth Patel, Brijesh V Padley, Simon PG Devaraj, Anand Radiol Cardiothorac Imaging Original Research BACKGROUND: The role of dual energy computed tomographic pulmonary angiography (DECTPA) in revealing vasculopathy in coronavirus disease 2019 (COVID-19) has not been fully explored. PURPOSE: To evaluate the relationship between DECTPA and disease duration, right ventricular dysfunction (RVD), lung compliance, D-dimer and obstruction index in COVID-19 pneumonia. MATERIALS AND METHODS: This institutional review board approved this retrospective study, and waived the informed consent requirement. Between March-May 2020, 27 consecutive ventilated patients with severe COVID-19 pneumonia underwent DECTPA to diagnose pulmonary thrombus (PT); 11 underwent surveillance DECTPA 14 ±11.6 days later. Qualitative and quantitative analysis of perfused blood volume (PBV) maps recorded: i) perfusion defect ‘pattern’ (wedge-shaped, mottled or amorphous), ii) presence of PT and CT obstruction index (CTOI) and iii) PBV relative to pulmonary artery enhancement (PBV/PAenh); PBV/PAenh was also compared with seven healthy volunteers and correlated with D-Dimer and CTOI. RESULTS: Amorphous (n=21), mottled (n=4), and wedge-shaped (n=2) perfusion defects were observed (M=20; mean age=56 ±8.7 years). Mean extent of perfusion defects=36.1%±17.2. Acute PT was present in 11/27(40.7%) patients. Only wedge-shaped defects corresponded with PT (2/27, 7.4%). Mean CTOI was 2.6±5.4 out of 40. PBV/PAenh (18.2 ±4.2%) was lower than in healthy volunteers (27 ±13.9%, p = 0.002). PBV/PAenh correlated with disease duration (β = 0.13, p = 0.04), and inversely correlated with RVD (β = -7.2, p = 0.001), persisting after controlling for confounders. There were no linkages between PBV/PAenh and D-dimer or CTOI. CONCLUSION: Perfusion defects and decreased PBV/PAenh are prevalent in severe COVID-19 pneumonia. PBV/PAenh correlates with disease duration and inversely correlates with RVD. PBV/PAenh may be an important marker of vasculopathy in severe COVID-19 pneumonia even in the absence of arterial thrombus. Radiological Society of North America 2020-10-29 /pmc/articles/PMC7605077/ /pubmed/33778632 http://dx.doi.org/10.1148/ryct.2020200428 Text en 2020 by the Radiological Society of North America, Inc. This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
spellingShingle Original Research
Ridge, Carole A
Desai, Sujal R
Jeyin, Nidhish
Mahon, Ciara
Lother, Dione L
Mirsadraee, Saeed
Semple, Tom
Price, Susanna
Bleakley, Caroline
Arachchillage, Deepa J
Shaw, Elizabeth
Patel, Brijesh V
Padley, Simon PG
Devaraj, Anand
Dual-Energy CT Pulmonary Angiography (DECTPA) Quantifies Vasculopathy in Severe COVID-19 Pneumonia
title Dual-Energy CT Pulmonary Angiography (DECTPA) Quantifies Vasculopathy in Severe COVID-19 Pneumonia
title_full Dual-Energy CT Pulmonary Angiography (DECTPA) Quantifies Vasculopathy in Severe COVID-19 Pneumonia
title_fullStr Dual-Energy CT Pulmonary Angiography (DECTPA) Quantifies Vasculopathy in Severe COVID-19 Pneumonia
title_full_unstemmed Dual-Energy CT Pulmonary Angiography (DECTPA) Quantifies Vasculopathy in Severe COVID-19 Pneumonia
title_short Dual-Energy CT Pulmonary Angiography (DECTPA) Quantifies Vasculopathy in Severe COVID-19 Pneumonia
title_sort dual-energy ct pulmonary angiography (dectpa) quantifies vasculopathy in severe covid-19 pneumonia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605077/
https://www.ncbi.nlm.nih.gov/pubmed/33778632
http://dx.doi.org/10.1148/ryct.2020200428
work_keys_str_mv AT ridgecarolea dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia
AT desaisujalr dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia
AT jeyinnidhish dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia
AT mahonciara dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia
AT lotherdionel dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia
AT mirsadraeesaeed dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia
AT sempletom dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia
AT pricesusanna dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia
AT bleakleycaroline dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia
AT arachchillagedeepaj dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia
AT shawelizabeth dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia
AT patelbrijeshv dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia
AT padleysimonpg dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia
AT devarajanand dualenergyctpulmonaryangiographydectpaquantifiesvasculopathyinseverecovid19pneumonia